CNO Financial Group, Inc. 5.125

What they do

CNO develops, markets, and administers health insurance, annuities, individual life insurance, and other insurance and financial services products. It operates through Consumer and Worksite Divisions, selling under the Bankers Life, Washington National, and Colonial Penn brands via exclusive agents, independent producers, and direct marketing. The company manages three insurance product lines—annuity, health, and life—plus investment and fee income segments.

Revenue drivers

• Annuity products — Collected premiums reached a quarterly record in Q2 2026, contributing to the investment income not allocated to product lines, which generated $49.4 million in Q2 2026.
• Health insurance products — Includes supplemental health and long-term care products; income from insurance products was $126.1 million in Q2 2026, up 22% year-over-year.
• Life insurance products — Individual life insurance sold through both Consumer and Worksite Divisions; total new annualized premiums were up 7% in Q2 2026.
• Worksite Division — Focuses on voluntary benefits sold in the workplace; achieved a quarterly record for new annualized premiums in Q2 2026.

Recent performance

In Q2 2026, CNO reported net income of $125.9 million, or $1.33 per diluted share, up 22% from $91.8 million in Q2 2025. Net operating income rose 37% to $119.5 million, or $1.26 per share, with operating EPS up 45% year-over-year. Total new annualized premiums grew 7%, marking 16 consecutive quarters of insurance sales growth. For full-year 2025, revenue was $4.49 billion and net income was $229.3 million. As of June 30, 2026, total assets were $39.86 billion and shareholder equity was $2.59 billion.

Strategy

Management emphasizes consistent, repeatable growth, citing 16 consecutive quarters of sales growth and agent count growth for 14 (Consumer) and 16 (Worksite) consecutive quarters. The company is investing in a TechMod initiative to modernize technology, which incurred $9.7 million in Q2 2026 expenses. CNO raises full-year 2026 operating EPS guidance by 8% at the midpoint, reflecting improved profitability. Focus remains on middle-income pre-retiree and retired markets through multi-channel distribution.

Risks

• Interest rate and market volatility — Exposure to interest rate risk and fluctuations in financial markets can negatively impact investment values and results of operations.
• Regulatory approvals for rate increases — The company relies on obtaining adequate and timely rate increases on health products, especially long-term care, which may not be granted.
• Mortality, morbidity, and healthcare costs — Higher than assumed mortality, morbidity, or healthcare utilization could reduce profitability of insurance products.
• Competitive pressures — Competitors with greater market share, financial resources, and brand recognition may limit CNO's ability to compete effectively.

Outlook

Management raised full-year 2026 operating earnings per share guidance by 8% at the midpoint, citing strong underlying fundamentals and continued profitability improvement. They expect continued sales growth, with 16 consecutive quarters already achieved. Quarterly records in Worksite Division NAP, annuity collected premiums, and brokerage/advisory client assets signal momentum. Forward-looking statements caution that results could differ due to market volatility, regulatory approvals, and other risks.